Journalists’ training in Ukraine: Reporting on barriers to treatment
Earlier this month (5 September), journalists joined an event arranged by our partner, 100% Life, in Kyiv, Ukraine, for training...
Ukraine eyes patent law reform after civil society push on medicines access
Ukrainian lawmakers are poised to approve sweeping patent reform legislation, driven in large part by a push by patients’ groups...
The Network vs. Abbvie – the first victory in reducing cost of HIV drug
The first victory has been won – and our partner in Ukraine intends to see the case through. On 4...
Patients demand AbbVie’s price bubble is burst – key HIV drug out of reach
AbbVie’s monopoly has hiked prices – it’s time to burst the bubble and get prices back down to earth. Activists...
Ukraine: HIV patients appeal against deadly patent monopoly
Unmerited patents protecting profit not patients – protesting & appealing the decisions so far. 50% of Ukraine’s budget for HIV...
Advocating for an improved patent applications process in Ukraine
The decision to grant or refuse a patent has an impact on the price of essential medicines – and huge...
All-Ukrainian Network of PLHIV continues to struggle for affordable LPV/r
Network of people living with HIV submits second opposition to patent on essential HIV drug in Ukraine On 30 January...
High price of lopinavir/ritonavir challenged in Ukraine
All-Ukrainian PLHIV Network challenges patent, and exclusive right to manufacture lopinavir/ritonavir.
Chronology of access to medicine campaign in Thailand
The fight for access to medicines in Thailand centers around the use of compulsory licensing on three drugs. The chronology on...